 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Articles |
OBJECTIVE: The objective of this article is to provide an overview of the biochemistry of oxygen metabolism, including the formation of free radicals and the role of endogenous antioxidants. Pathophysiologic correlates underlying the clinical manifestations of oxygen toxicity are reviewed and management strategies are outlined. DATA SOURCES: References from basic science and clinical journals were selected from the authors' files and from a search of a computerized database of the biomedical literature. STUDY SELECTION: Articles selected for review included both historical and current literature concerning the biochemistry and pathophysiology of oxygen toxicity in animals and humans. DATA SYNTHESIS: The benefits of oxygen therapy have been known for many years; however, its potential toxicity has not been recognized until the last two decades. The lungs, the eyes, and, under certain conditions, the central nervous system are the organs most affected by prolonged exposure to hyperoxic environments. Free radical formation during cellular metabolism under hyperoxic conditions is recognized as the biochemical basis of oxygen injury to cells and organs. Endogenous antioxidants are a primary means of detoxifying reactive oxygen species and preventing hyperoxia-induced cellular damage. When this defense fails or is overwhelmed by the excessive production of hyperoxia-induced free-radical species, distinctive morphologic changes occur at the cellular level. The amount of hyperoxia required to cause cellular damage and the time course of these changes vary from species to species and from individual to individual within the same species. Age, nutritional status, presence of underlying diseases, and certain drugs may influence the development of oxygen toxicity. CONCLUSIONS: There is currently no reliably effective drug for preventing or delaying the development of oxygen toxicity in humans. Use of the lowest effective oxygen concentration, the avoidance of certain drugs, and attention to nutritional and metabolic factors remain the best means currently available to avoid or minimize oxygen toxicity. Research is continuing into more effective ways to prevent, diagnose, and treat this disorder.
This article has been cited by other articles:
|
|
 |
|
  J. Li Campian, X. Gao, M. Qian, and J. W. Eaton Cytochrome c Oxidase Activity and Oxygen Tolerance J. Biol. Chem., April 27, 2007; 282(17): 12430 - 12438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sonveaux, I. I. Lobysheva, O. Feron, and T. J. McMahon Transport and Peripheral Bioactivities of Nitrogen Oxides Carried by Red Blood Cell Hemoglobin: Role in Oxygen Delivery Physiology, April 1, 2007; 22(2): 97 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Campian, M. Qian, X. Gao, and J. W. Eaton Oxygen Tolerance and Coupling of Mitochondrial Electron Transport J. Biol. Chem., November 5, 2004; 279(45): 46580 - 46587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Shenberger, M. H. Adams, and S. G. Zimmer Oxidant-Induced Hypertrophy of A549 Cells Is Accompanied by Alterations in Eukaryotic Translation Initiation Factor 4E and 4E-Binding Protein-1 Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 250 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Mantell, T. H. Shaffer, S. Horowitz, R. Foust III, M. R. Wolfson, C. Cox, P. Khullar, Z. Zakeri, L. Lin, J. A. Kazzaz, et al. Distinct patterns of apoptosis in the lung during liquid ventilation compared with gas ventilation Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L31 - L41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tahepold, A. Ruusalepp, G. Li, J. Vaage, J. Starkopf, and G. Valen Cardioprotection by breathing hyperoxic gas--relation to oxygen concentration and exposure time in rats and mice Eur. J. Cardiothorac. Surg., June 1, 2002; 21(6): 987 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Levy, Y.-H. Tsai, A. Reaume, and T. M. Bray Cellular response of antioxidant metalloproteins in Cu/Zn SOD transgenic mice exposed to hyperoxia Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L172 - L182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Van Voorhies and S Ward Broad oxygen tolerance in the nematode Caenorhabditis elegans J. Exp. Biol., January 8, 2000; 203(16): 2467 - 2478. [Abstract] [PDF]
|
|
|
|
|
|
Y. Li, W. Zhang, L. L. Mantell, J. A. Kazzaz, A. M. Fein, and S. Horowitz Nuclear Factor-kappa B Is Activated by Hyperoxia but Does Not Protect from Cell Death J. Biol. Chem., August 15, 1997; 272(33): 20646 - 20649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Kazzaz, J. Xu, T. A. Palaia, L. Mantell, A. M. Fein, and S. Horowitz Cellular Oxygen Toxicity. OXIDANT INJURY WITHOUT APOPTOSIS J. Biol. Chem., June 21, 1996; 271(25): 15182 - 15186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Johnson The Emerging Role of Vitamins as Antioxidants Arch Fam Med, September 1, 1994; 3(9): 809 - 818. [Abstract] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
